These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6663150)

  • 1. Concentrations of a new antitumor agent, 1-hexylcarbamoyl-5-fluorouracil in serum and gynecologic tumor tissue.
    Sawada M; Matsui Y; Okudaira Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Dec; 35(12):2421-6. PubMed ID: 6663150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estimation of 1-hexylcarbamoyl-5-fluorouracil (HCFU) and 5-FU concentrations in sera and resected specimens from patients with ovarian tumors].
    Takizawa K; Ino Y; Isono T; Sato M; Yokoo I; Iguchi T; Takeda Y
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):697-702. PubMed ID: 3355187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of urokinase on the transfer of 1-hexylcarbamoyl-5-fluorouracil (HCFU) into the blood, bile and pancreatic juice].
    Kato S; Matsuno S; Kakizaki K; Fukaya Y; Akaishi S
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2134-8. PubMed ID: 4062312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum concentration of HCFU and 5-FU after oral administration of HCFU in postoperative digestive cancer patients].
    Kuroda Y; Ohkuma R; Ohsato K
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1831-6. PubMed ID: 1519925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of thermochemotherapy [1-hexylcarbamoyl-5-fluorouracil (HCFU) combined with hyperthermia]: a basic study on the most effective timing and sequence in vivo.
    Sakurai K; Yoshiga K; Tsumura M; Takada K
    Anticancer Res; 1996; 16(5A):2729-33. PubMed ID: 8917379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of a new antitumor drug, 1-hexylcarbamoyl-5-fluorouracil (HCFU), administered orally: an HCFU clinical study group report.
    Koyama Y; Koyama Y
    Cancer Treat Rep; 1980; 64(8-9):861-7. PubMed ID: 7448823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [5-FU and HCFU concentrations in serum and tissues in hepatocellular carcinoma after HCFU oral administration].
    Suenaga M
    Gan No Rinsho; 1988 May; 34(6):744-8. PubMed ID: 2837592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Distribution of 1-hexycarbamoyl-5-fluorouracil in rats and human patients, and clinical results in patients with colorectal cancer].
    Takashima S; Kinami Y; Kiriyama M; Tomita F; Ueno K; Miyazaki I
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):549-55. PubMed ID: 3954377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the optimum method of administration of a new antineoplastic agent, HCFU, based on the serum 5-FU concentration following oral administration].
    Hara Y; Kono A; Tanaka M
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):293-300. PubMed ID: 7184403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Hexylcarbamoyl-5-fluorouracil is more cytostatic than 5-fluorouracil against human tumors in vitro.
    Maehara Y; Kusumoto H; Anai H; Kusumoto T; Hiramoto Y; Sugimachi K
    Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1511-5. PubMed ID: 3678315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transfer of carmofur (HCFU) to the serum, bile, pancreatic juice and pancreatic tumor tissue in the cases of peri-pancreatic head cancer].
    Akaishi S; Kobari M; Yusa T; Yamanami H; Furukawa T; Matsuno S
    Gan To Kagaku Ryoho; 1995 Apr; 22(5):659-64. PubMed ID: 7717718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose 1-hexylcarbamoyl-5-fluorouracil (HCFU) recommended for cirrhotic patients with hepatocellular carcinoma.
    Takenaka K; Kanematsu T; Shimada M; Sugimachi K
    Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1191-5. PubMed ID: 2548869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic fate of 1-hexylcarbamoyl-5-fluorouracil after oral administration in mice.
    Iigo M; Nakamura A; Kuretani K; Hoshi A
    Xenobiotica; 1980 Nov; 10(11):847-54. PubMed ID: 7467400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of 1-hexylcarbamoyl-5-fluorouracil (HCFU), a new antitumour agent, in rats, rabbits and dogs.
    Kobari T; Iguro Y; Ujiie A; Namekawa H
    Xenobiotica; 1981 Jan; 11(1):57-62. PubMed ID: 7222730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 1-hexylcarbamoyl-5-fluorouracil on spontaneous mammary adenocarcinoma of mice.
    Tokuzen R; Iigo M; Hoshi A; Kuretani K
    Gan; 1980 Oct; 71(5):724-8. PubMed ID: 7227721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of 1-hexylcarbamoyl-5-fluorouracil (HCFU) in hepatocellular carcinoma].
    Shiraishi K; Kubo Y; Majima Y; Sato K; Sakemi T; Sakai T; Hirai K; Ninomiya F; Abe M; Tanikawa K
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2348-55. PubMed ID: 6093712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HCFU and 5-fluorouracil levels in the blood and tissue of hepatocellular carcinoma after oral administration of HCFU].
    Mori M; Hamazaki K; Mimura H; Orita K
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3763-8. PubMed ID: 2556972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration and HCFU alone as postoperative adjuvant chemotherapy for colorectal cancer.
    Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Nakamura T; Nakasato H; Orita K
    Anticancer Res; 2000; 20(5C):3727-34. PubMed ID: 11268446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic fate on 1-hexylcarbamoyl-5-fluorouracil and 5-fluorouracil in mice bearing ascites sarcoma 180.
    Iigo M; Kuretani K; Hoshi A
    J Natl Cancer Inst; 1981 Feb; 66(2):345-9. PubMed ID: 6935483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of post operative maintenance chemotherapy against ovarian cancer].
    Sawada M; Ozaki M; Hongo J; Hirota Y; Inagaki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1115-20. PubMed ID: 3611882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.